| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |